The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 28, 2017

Filed:

Oct. 04, 2013
Applicant:

Abbott Laboratories, Abbott Park, IL (US);

Inventors:

Suzette Pereira, Westerville, OH (US);

Sean Garvey, Columbus, OH (US);

Neile Edens, Columbus, OH (US);

Assignee:

ABBOTT LABORATORIES, Abbott Park, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 33/30 (2006.01); A23L 33/00 (2016.01); A61K 31/353 (2006.01); A61K 38/01 (2006.01); A61K 35/20 (2006.01); A61K 36/48 (2006.01); A23L 2/66 (2006.01); A61K 9/00 (2006.01); A61K 36/82 (2006.01); A61K 38/39 (2006.01);
U.S. Cl.
CPC ...
A61K 33/30 (2013.01); A23L 2/66 (2013.01); A23L 33/105 (2016.08); A23L 33/16 (2016.08); A23L 33/17 (2016.08); A23L 33/175 (2016.08); A23L 33/19 (2016.08); A23L 33/195 (2016.08); A23L 33/40 (2016.08); A61K 9/0095 (2013.01); A61K 31/353 (2013.01); A61K 35/20 (2013.01); A61K 36/48 (2013.01); A61K 36/82 (2013.01); A61K 38/011 (2013.01); A61K 38/018 (2013.01); A61K 38/39 (2013.01); A23V 2002/00 (2013.01);
Abstract

Disclosed herein are methods for enhancing the efficacy of epigallocatechin gallate ('EGCg') in mitigating skeletal muscle loss in a subject. Providing EGCg to a subject in a nutritional composition reduces muscle protein degradation, thereby mitigating skeletal muscle loss in the subject. The combination of EGCg with zinc in a nutritional composition enhances the mitigating effect that EGCg has on muscle loss. Specifically, when used in combination, a nutritional composition containing both EGCg and zinc requires less EGCg to obtain the same mitigating effect that occurs in the same nutritional composition containing EGCg but no zinc.


Find Patent Forward Citations

Loading…